新世界(00017.HK)黃浩賢:「柏傲莊II」第四輪銷售A組已沽清
新世界發展(00017.HK)營業及市務部總監黃浩賢指,大圍站上蓋項目「柏傲莊II」第四輪銷售中的A組約中午12時半已售罄,預期315伙可即日沽清或近沽清。他樂見施政報告公布後市場氣氛正面,認為用家主導市場。而樓市氣氛熱鬧,反映市況健康。
他透露,將積極與合作夥伴研究,最快下月將餘下未推出的特色單位招標發售。第一及二期之撻訂貨,預計需重新入票登記抽籤。至於「柏傲莊」第三期料最快明年上半年推。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.